Talk:Panitumumab
From Wikipedia, the free encyclopedia
 |
This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme. |
||
| Stub | This article has been rated as Stub-Class on the assessment scale. |
||
| Low | This article is on a subject of low-importance within molecular and cellular biology. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
This is a brand new drug (just licenced in spetember 2006) similar to cetuximab, infact in theory it should be better. I will try and develop it when i have some time, but it would be silly to delete it. It is certainly not spam.StephP 23:29, 14 October 2006 (UTC)
I think panitumumab is IgG2, not IgG1. Could the author please check? Thanks.
